This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting for September results and possible share buyback
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
FDC Limited will hold a Board meeting on October 27, 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. The Board will also consider a possible share buyback through a tender offer, but the amount, price and terms have not been decided. The trading window remains closed until 48 hours after the results are announced.
The results may drive the stock price. A buyback could support shareholder confidence, but it has not been approved and key terms are unknown.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹572.1 Cr | ₹473.0 Cr | +21.0% |
| Operating profit | ₹47.47 Cr | ₹17.47 Cr | +171.8% |
| Profit after tax | ₹49.06 Cr | ₹28.37 Cr | +72.9% |
| EBITDA margin | 11.2% | 7.2% | +4.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.